Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03304106 · ClinicalTrials.gov registry record · NA

Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population

A NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral, sponsored by Cochlear.

Completed
Registry status
NA
Development phase
102
Enrollment target
9
Study locations

NCT03304106 is a NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral that has completed, run by Cochlear. The registered enrollment target is 102 participants, below the 125-participant average among 4 other Cochlear Implant trials with a reported enrollment target (18% lower). The trial reports 9 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03304106, a NA study of Cochlear Implant and Sensorineural Hearing Loss, Bilateral, has completed, sponsored by Cochlear.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target
9
Study locations

Study Summary

Use of Artificial Intelligent (AI) technology to assist audiologists in programming cochlear implants.

Interventions

  • DEVICE Commercially available cochlear implant and AI system

Study Locations (9)

Colorado

  • Rocky Mountain Ear Center - Englewood

Maryland

  • Greater Baltimore Medical Center - Baltimore

Michigan

  • University of Michigan - Ann Arbor

Missouri

  • Midwest Ear Institute - Kansas City

New York

  • New York University - New York

Oklahoma

  • Hearts for Hearing - Oklahoma City

Tennessee

  • Vanderbilt University Medical Center - Nashville

Texas

  • Cochlear Hearing Center Houston - Houston

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2017-10-19
Est. Completion 2019-09-18
Phase NA

Sponsor

Cochlear

34 total trials

What the Registry Record Tells You About NCT03304106

The ClinicalTrials.gov registry entry for NCT03304106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 125-participant average among 4 other Cochlear Implant trials with a reported enrollment target (18% lower). The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cochlear Implant appearing as the primary indexed condition, and to 1 intervention - of which Commercially available cochlear implant and AI system is the first listed.

NCT03304106 reports 9 study locations spanning 9 distinct geographic areas - top geographies include Colorado, Maryland, Michigan.

Frequently Asked Questions

What is clinical trial NCT03304106 about?

NCT03304106 is a clinical study titled "Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population". Use of Artificial Intelligent (AI) technology to assist audiologists in programming cochlear implants.

What is the current status of trial NCT03304106?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-10-19. Estimated completion is 2019-09-18.

What conditions does trial NCT03304106 study?

This clinical trial studies the following conditions: Cochlear Implant, Sensorineural Hearing Loss, Bilateral.

What interventions are being tested in trial NCT03304106?

The interventions under investigation include: Commercially available cochlear implant and AI system (DEVICE).

Who is sponsoring clinical trial NCT03304106?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03304106 being conducted?

This trial has 9 study locations across Colorado, Maryland, Michigan, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cochlear Implant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.